A61K 35/18
Erythrocytes
Official title: Erythrocytes (haemoglobin A61K38/42)
A61K35/18 (Erythrocytes) appears on 357 US grants and 499 published applications in this corpus.
Search patents in A61K- Granted patents
- 357
- Published applications
- 499
- Assignees
- 262
- Inventors
- 830
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 8 | 0 |
| 1995 | 5 | 0 |
| 1996 | 13 | 0 |
| 1997 | 8 | 0 |
| 1998 | 10 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 3 |
| 2002 | 1 | 8 |
| 2003 | 5 | 13 |
| 2004 | 3 | 9 |
| 2005 | 7 | 8 |
| 2006 | 4 | 12 |
| 2007 | 6 | 8 |
| 2008 | 2 | 10 |
| 2009 | 4 | 10 |
| 2010 | 6 | 16 |
| 2011 | 5 | 14 |
| 2012 | 6 | 20 |
| 2013 | 12 | 13 |
| 2014 | 10 | 25 |
| 2015 | 14 | 30 |
| 2016 | 9 | 30 |
| 2017 | 12 | 16 |
| 2018 | 22 | 37 |
| 2019 | 23 | 41 |
| 2020 | 22 | 31 |
| 2021 | 22 | 38 |
| 2022 | 12 | 34 |
| 2023 | 9 | 22 |
| 2024 | 12 | 17 |
| 2025 | 12 | 14 |
| 2026 | 9 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Living cells engineered with polyphenol-functionalized biologically active nanocomplexes28 Jul 2026US 12,692,514 B2President and Fellows of Harvard College
- Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo5 May 2026US 12,616,720 B2RegenLab USA LLC
- Methods for the production of pharmaceutical agents21 Apr 2026US 12,605,405 B2Orthogen AG
- GABA agonists and antagonists affect differentiation of hematopoietic stem cells and megakaryocyte progenitors31 Mar 2026US 12,589,114 B2The Board of Trustees of the Leland Stanford Junior University
- Blood substitutes comprising hemoglobin and methods of making24 Mar 2026US 12,582,703 B2VirTech Bio, Inc.
- Formulations and Methods for Collecting and Storing Blood and Blood Products1 Oct 2026US 2026/0294972 A1Hemerus Medical, LLC
- Rrx-001 for minimizing post-infarct adverse ventricular remodeling and complications27 Aug 2026US 2026/0248762 A1EpicentRx, Inc.
- Nucleic acid loaded red blood cell extracellular vesicles27 Aug 2026US 2026/0250649 A1Carmine Therapeutics Pte. Ltd.
- Compositions and methods for reducing adverse side effects in cancer treatment20 Aug 2026US 2026/0240810 A1EpicentRx, Inc.
- Composition for immunizing against parasite infection and methods using the same13 Aug 2026US 2026/0232781 A1Yale University
Most cited
By later US patents
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Composition and method for the repair and regeneration of cartilage and other tissues193US 7,148,209 B2Ecole Polytechnique · 2006
- Flow electroporation chamber and method176US 5,720,921 AEntreMed, Inc. · 1998
- Method of cryopreserving a suspension of biological material150US 5,364,756 ALifeCell Corporation · 1994
- Polyethylene glycol-protein compositions which reduce the antigenic display of red blood cells111US 6,129,912 AThe UAB Research Foundation · 2000